167 related articles for article (PubMed ID: 33385873)
1. Survival outcomes in sinonasal carcinoma with neuroendocrine differentiation: A NCDB analysis.
Issa K; Ackall F; Jung SH; Li J; Jang DW; Rangarajan SV; Abi Hachem R
Am J Otolaryngol; 2021; 42(2):102851. PubMed ID: 33385873
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
Robin TP; Jones BL; Gordon OM; Phan A; Abbott D; McDermott JD; Goddard JA; Raben D; Lanning RM; Karam SD
Cancer; 2017 Aug; 123(16):3040-3049. PubMed ID: 28369832
[TBL] [Abstract][Full Text] [Related]
3. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses.
Babin E; Rouleau V; Vedrine PO; Toussaint B; de Raucourt D; Malard O; Cosmidis A; Makaeieff M; Dehesdin D
J Laryngol Otol; 2006 Apr; 120(4):289-97. PubMed ID: 16526967
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH
Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906
[TBL] [Abstract][Full Text] [Related]
5. Predictors of survival outcomes in sinonasal squamous cell carcinoma: an analysis of the National Cancer Database.
Farrell NF; Mace JC; Detwiller KY; Li R; Andersen PE; Smith TL; Clayburgh DR; Geltzeiler M
Int Forum Allergy Rhinol; 2021 Jun; 11(6):1001-1011. PubMed ID: 33226198
[TBL] [Abstract][Full Text] [Related]
6. The importance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma.
van der Laan TP; Bij HP; van Hemel BM; Plaat BE; Wedman J; van der Laan BF; Halmos GB
Eur Arch Otorhinolaryngol; 2013 Sep; 270(9):2565-8. PubMed ID: 23740425
[TBL] [Abstract][Full Text] [Related]
7. Multimodality treatment for sinonasal neuroendocrine carcinoma.
Mitchell EH; Diaz A; Yilmaz T; Roberts D; Levine N; DeMonte F; Hanna EY; Kupferman ME
Head Neck; 2012 Oct; 34(10):1372-6. PubMed ID: 22052583
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with treatment receipt and overall survival for patients with locally advanced large cell neuroendocrine carcinoma of the lung: A National Cancer Database analysis.
Limonnik V; Abel S; Finley GG; Long GS; Wegner RE
Lung Cancer; 2020 Dec; 150():107-113. PubMed ID: 33126090
[TBL] [Abstract][Full Text] [Related]
9. Nasal Cavity Squamous Cell Carcinoma: Factors Associated With Treatment Outcomes and Potential Organ Preservation.
Issa K; Teitelbaum J; Smith BD; Wang F; Ackall F; Sargi Z; Rangarajan SV; Jung SH; Jang DW; Abi Hachem R
Am J Rhinol Allergy; 2023 Jan; 37(1):35-42. PubMed ID: 36189818
[TBL] [Abstract][Full Text] [Related]
10. Sinonasal neuroendocrine carcinoma: a population-based analysis of incidence and survival.
Patel TD; Vazquez A; Dubal PM; Baredes S; Liu JK; Eloy JA
Int Forum Allergy Rhinol; 2015 May; 5(5):448-53. PubMed ID: 25727332
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck.
Chen AM; Daly ME; El-Sayed I; Garcia J; Lee NY; Bucci MK; Kaplan MJ
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):338-43. PubMed ID: 18207030
[TBL] [Abstract][Full Text] [Related]
13. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
[TBL] [Abstract][Full Text] [Related]
14. Nasal and paranasal sinus mucosal melanoma: Long-term survival outcomes and prognostic factors.
Abt NB; Miller LE; Mokhtari TE; Lin DT; Richmon JD; Deschler DG; Varvares MA; Puram SV
Am J Otolaryngol; 2021; 42(6):103070. PubMed ID: 33930681
[TBL] [Abstract][Full Text] [Related]
15. Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients.
Guntinas-Lichius O; Kreppel MP; Stuetzer H; Semrau R; Eckel HE; Mueller RP
Eur J Surg Oncol; 2007 Mar; 33(2):222-8. PubMed ID: 17127030
[TBL] [Abstract][Full Text] [Related]
16. Survival Outcomes in Sinonasal Poorly Differentiated Squamous Cell Carcinoma.
Ackall FY; Issa K; Barak I; Teitelbaum J; Jang DW; Jung SH; Goldstein B; Carrau R; Abi Hachem R
Laryngoscope; 2021 Apr; 131(4):E1040-E1048. PubMed ID: 32959912
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.
Cattrini C; Cerbone L; Rubagotti A; Zinoli L; Latocca MM; Messina C; Zanardi E; Boccardo F
Clin Genitourin Cancer; 2019 Aug; 17(4):e724-e732. PubMed ID: 31160193
[TBL] [Abstract][Full Text] [Related]
18. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
[TBL] [Abstract][Full Text] [Related]
19. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
Kuo P; Manes RP; Schwam ZG; Judson BL
Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of squamous cell carcinoma associated with sinonasal inverted papilloma.
Yasumatsu R; Nakashima T; Sato M; Nakano T; Kogo R; Hashimoto K; Sawatsubashi M; Nakagawa T
Auris Nasus Larynx; 2017 Feb; 44(1):98-103. PubMed ID: 27108101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
